Business / Finance

RSS

Sycamore Ventures announces acquisition of Trunk Health Products

Sycamore Ventures announced today that the company has acquired Trunk Health Products. Trunk Health Products resells and markets health and nutrition products through wholesale and retail outlets.

6 Jan 2012

Essilor signs five new partnership agreements in North Africa, Latin America

Essilor has further expanded its presence in fast-growing markets by signing five new partnership agreements in North Africa and Latin America.

6 Jan 2012

CLC Bio reports 30% increase in software sales in 2011

Today, CLC bio is pleased to announce that the positive growth rates of recent years have continued in 2011 with a 30% increase in software sales and a growth in operating profit of more than 50% compared to 2010.

5 Jan 2012

Midatech raises £6.3M through private investment round

Midatech Ltd., a global leader for the design, development, synthesis and manufacture of nanomedicines, announced today it has raised £6.3 million through a private investment round.

5 Jan 2012

Probiodrug secures EUR 15M for clinical development of PQ912

Probiodrug AG today announced it has secured EUR 15 million additional financing for the ongoing development of its glutaminyl cyclase (QC) inhibitor program. The lead compound, PQ912, its first QC inhibitor, is in clinical development for the treatment of Alzheimer's disease.

5 Jan 2012

NGP receives investment from Abbott to develop NGP 555 for AD

NeuroGenetic Pharmaceuticals, Inc. (NGP), a privately held biopharmaceutical company focused on Alzheimer's disease (AD) therapeutics, has received an investment from Abbott Biotech Ventures.

5 Jan 2012

AAIPharma announces acquisition of Celsis Analytical Services

AAIPharma Services Corp., a leading provider of pharmaceutical product development services, announced today it has acquired Celsis Analytical Services, a division of Celsis International Ltd. that performs material testing services for the pharmaceutical, biotechnology and manufacturing sectors.

4 Jan 2012

Pharmalink raises SEK 35 million to further advance Nefecon and Busulipo

Pharmalink AB, today announces it has raised SEK 35 million through a rights issue of new shares to the Company's existing shareholders, including Industrifonden.

4 Jan 2012

BSD expands sales programs for MicroThermX Microwave Ablation System

BSD Medical Corporation, a leading provider of medical systems that utilize heat therapy to treat cancer, announced today that the Company is approaching 100 patients successfully treated with the MicroThermX Microwave Ablation System at hospitals throughout the U.S.

4 Jan 2012

ARC Healthcare closes acquisition of medical office building in Willingboro

American Realty Capital Healthcare Trust, Inc. announced that on December 29, 2011, the Company closed its acquisition of a fee simple interest in a medical office building located in Willingboro, New Jersey, for a purchase price of approximately $3.3 million, exclusive of closing costs.

4 Jan 2012

Ensign acquires real estate assets of Orem Rehabilitation & Nursing Center

The Ensign Group, Inc., announced today that it has acquired the underlying real estate and other operating assets of Orem Rehabilitation & Nursing Center, a 108-bed skilled nursing facility in Orem, Utah.

4 Jan 2012

Bionovo enters $5M securities purchase agreement with Socius

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced that it has entered into a $5 million securities purchase agreement with Socius CG II, Ltd. ("Socius"), a Bermuda-based subsidiary of Socius Capital Group, LLC.

4 Jan 2012

Quest Diagnostics to acquire S.E.D. Medical Labs

S.E.D. Medical Laboratories will soon become part of Quest Diagnostics Incorporated, the world leader in diagnostic testing, information and services, through a definitive agreement signed today by Lovelace Health System and Quest Diagnostics.

From Quest Diagnostics 4 Jan 2012

Landec second quarter revenues increase 16% to $81.6 million

Landec Corporation, today reported results for the second quarter and first half of fiscal year 2012. Revenues for the second quarter of fiscal year 2012 increased 16% to $81.6 million compared to revenues of $70.2 million for the second quarter of fiscal year 2011.

4 Jan 2012

iCAD enters $15M debt facility agreement with Deerfield Management

iCAD, Inc., an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that it has entered into a five year, $15 million debt facility agreement with Deerfield Management Company LP, a leading healthcare investment fund.

3 Jan 2012

Accelrys announces acquisition of VelQuest

Accelrys, Inc., a leading scientific enterprise research and development software and services company, today announced that it has acquired privately-held VelQuest Corporation for $35 million in an all-cash transaction.

3 Jan 2012

Regeneron, Genentech enter non-exclusive license and partial settlement agreement for EYLEA

Regeneron Pharmaceuticals, Inc. today announced that the Company has entered into a non-exclusive license and partial settlement agreement with Genentech, Inc., a member of the Roche Group relating to U.S. ophthalmic sales of EYLEA (aflibercept) Injection.

3 Jan 2012

Cutera to purchase assets of IRIDEX' global aesthetic business

Cutera, Inc. and IRIDEX Corporation today announced that the companies have entered into a binding agreement for Cutera to purchase certain assets of IRIDEX' global aesthetic business for approximately $5.1 million.

3 Jan 2012

MedPro completes acquisition of Princeton

Medical Protective Company (MedPro), a Berkshire Hathaway subsidiary, announced today that it has completed the acquisition of Princeton Insurance Company (Princeton) from Medical Liability Mutual Insurance Company.

3 Jan 2012

Artimplant to take over responsibility for sales of Artelon CMC Spacer

With effect from January 1, 2012, Artimplant will take over responsibility for sales of Artelon® CMC Spacer, previously handled by the licensee SBi. This is an integral part of Artimplant's focus on reinforcing its presence on the very important US market.

3 Jan 2012